In China, the group was hit by a smaller patient load at its RafflesHospital Chongqing as well as the closure of clinics due to the movement restrictions imposed there.
Analysts are maintaining a cautious stance on Raffles Medical Group following the announcement of its 1H2020 results on July 27.
In what RHB analyst Juliana Cai deems “results infected by Covid-19”, the group posted a 38.2% drop in earnings to $17.2 million. This comes on the back of a deferment in elective surgeries and a dip in foreign patients, particularly during the circuit breaker period in Singapore.
